DRUG · Mapped RxNorm record
Escitalopram
Normalized identity: escitalopramView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Escitalopram in Adult Patients With Major Depressive Disorder
NCT00668525
Drugs and interventions used in this trial
3 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Placebo
Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
Escitalopram
Normalized identity: escitalopramView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedEscitalopram in Adult Patients With Major Depressive Disorder
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
EscitalopramDRUG · verified · RxNorm: escitalopram
PlaceboDRUG
EscitalopramDRUG · verified · RxNorm: escitalopram
Sponsors & collaborators
Forest Laboratorieslead sponsor
Mapped research locations
New YorkNew York, United States2OmahaNebraska, United States2MemphisTennessee, United States2HoustonTexas, United States1PhiladelphiaPennsylvania, United States1BaltimoreMaryland, United States1St LouisMissouri, United States1AtlantaGeorgia, United States1San AntonioTexas, United States1SeattleWashington, United States1PortlandOregon, United States1Washington D.C.District of Columbia, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00668525 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.